AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Elevance Health Plunges 5.21% on Lowered Earnings Outlook
Generated by AI AgentAinvest Movers Radar
Tuesday, May 13, 2025 7:33 am ET1min read
On May 13, 2025, Elevance Health's stock experienced a significant drop of 5.21% in pre-market trading, indicating a notable shift in investor sentiment.
Analysts have revised their expectations for Elevance Health's second-quarter earnings, with Zacks Research analyst K. Dey now projecting earnings per share of $9.36, down from the previous estimate of $9.85. This adjustment reflects a more cautious outlook on the company's financial performance.
Elevance Health's current Zacks Rank of 3 suggests that the stock is expected to perform in line with the broader market, rather than outperform. This rating indicates a neutral stance on the company's prospects, which may contribute to the recent decline in stock price.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Galiano Gold Surges 5.1% Despite Lack of Technical Confirmation – What’s Fueling the Move?
Dec.23 2025
NLY Shares Soar 2.51% Intraday on $2.5B Equity Offering Program
Dec.22 2025
Lam Research Soars 13.09% on AI/HPC Demand, Analyst Upgrades
Dec.22 2025
WisdomTree Shares Surge 8.75% as Japan Hedged ETF Outperforms Unhedged 8x in 5 Years
Dec.22 2025
FBS Global Shares Rally 18.39% on Earnings Turnaround, Seven-Day Gains Reach 14.23%
Dec.22 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet